Active Health
PerPrev-CID

Personalised Disease Prediction and Prevention in Chronic Inflammatory Disorders

€13.MFunding
60Months
15Partners

Fact sheet

Programme
Horizon Europe & sub-programmes
Companies
EURICE
Duration
60 months (January 2025 – December 2029)
Project funding
€ 13,500,000.00
Project partners
15
Project website
https://www.perprev-cid.eu/

Project contact(s)

Your contact
Dr Lorena Consolino
Research & Impact Manager

About the project

Rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) are two chronic inflammatory diseases that lack risk prediction and early preventive strategies. The European research project PerPrev-CID seeks to address this gap by developing early diagnostic methods and innovative assessment tools. Through analysing clinical and molecular data of patients and at-risk individuals, the project will identify early markers and relapse predictors, while also creating digital monitoring tools like health apps and wearables. Additionally, a proof-of-concept study will test the effectiveness of a nutritional intervention targeting the tryptophan pathway. Lastly, the project aims to advance patient-centred research and clinical practice by involving patients as active stakeholders.

Coordinator

Prof. Dr Philip Rosenstiel
Universitätsklinikum Schleswig-Holstein (UKSH)
Email coordinator